Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02438722
Brief Title: S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

First Submitted : May 6, 2015
First Submitted that Met QC Criteria : May 6, 2015
First Posted : May 8, 2015 (Estimate)

Results First Submitted : December 10, 2020
Results First Submitted that Met QC Criteria : February 23, 2021
Results First Posted : March 17, 2021

Last Update Submitted that Met QC Criteria : February 23, 2021
Last Update Posted : March 17, 2021